SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

Stealth 360™

Peripheral Orbital Atherectomy System

Stealth 360 Peripheral Orbital Atherectomy Device
Features

Some debulk. Some fracture.
Stealth 360™ Peripheral Orbital Atherectomy System does both with a single device.

The Stealth 360™ Peripheral Orbital Atherectomy System safely debulks intimal calcium and fractures medial calcium with its unique dual-mechanism of action, offering a comprehensive calcium solution - all with a single device.1-4

Debulks Intimal Calcium + Fractures Medial Calcium

Debulks intimal calcium
Fractures medial calcium

Watch the video to see how the Stealth 360™ Peripheral Orbital Atherectomy System simultaneously debulks intimal calcium and fractures medial calcium.1-4

Stealth 360™ Peripheral Orbital Atherectomy System provides long-term outcomes, proven safety, and high versatility.

Stealth 360 System provides long-tern outcomes, safety and high versatility.

Long-Term Efficacy:

  • 100% freedom from major amputation at 3 years in RC 2-3 (95% in RC 4-5, 89% n RC 6)4
  • 82.1% patency at 1 year (RC 2-3)5
  • 89.7% patency at 2 years (RC 2-3)6
  • Significant would healing in CLTI group (RC 4-6) at 2 years6

Proven Safety Record:

  • Excellent procedural safety7-11
  • Using orbital atherectomy + low pressure PTA resulted in low rate of major adverse events10 and less bailout stents12

Versatile Usage:

  • A single crown can be used in vessels above- and below-the-knee and in different types of calcium and lesions1,2,9,10,12
    • Moderate to severe
    • Soft/hard
    • Short/long
    • Eccentric
    • Concentric
  • Low-profile design can help minimize access site complications13 and improve procedural range4
  • Prepares small and large vessels for treatment without the need to up-size your catheter and sheath size1,2

Explore additional products: Learn how our comprehensive portfolio offers individualized solutions for every step of lower limb intervention, from access to close.

Learn More
Peripheral artery disease
Peripheral artery disease

References

*Count updated 25 Mar 2020 - subject to change (includes PAD I, PAD II, OASIS, CONFIRM, CALCIUM 360, COMPLIANCE 360, TRUTH, CLARITY I, LIBERTY 360, OPTIMIZE BTK, & REACH PVI)

  1. Adams GL, et al. J Cardiovasc Transl Res. 2011;4(2):220-229.
  2. Mustapha JA, et al. J Crit Limb Ischem. 2021;1(3):E118-E125.
  3. Data on file at Abbott. Clinical Report Memo on Peripheral and Coronary OAS Pulsatile Force and Calcium Fracture. 2021.
  4. Giannopoulos S, et al. J Endovasc Ther. 2020;27(5):714-725.
  5. Mustapha JA. Late Breaking: LIBERTY 360 Trial 2-Year Update. Presented at AMP 2018.
  6. Adams G, et al. J Vasc Surg. 2019;70(5, Suppl):e188-e189.
  7. Martinsen B, Evaluation and Use of Atherectomy Devices for CLI in US, Japan, and EU: Industry View. Presented at VIVA 2017. (Includes directional, rotational, laser)
  8. Data on file at Abbott.
  9. Das T, et al. Catheter Cardiovasc Interv. 2014;83:115-122. (Flow-limiting dissections and embolization were not tracked in 1146 lesions)
  10. Shammas NW, et al. J Endovasc Ther. 2012;19:480-488.
  11. Babaev A, et al. Vasc Endovascular Surg. 2015;49:188-194.
  12. Dattilo R, et al. J Invasive Cardiol. 2014;26(8):355-360.
  13. Bosiers M, et al. J Endovasc Ther. 2013;20(6):746-756.

MAT-2402038 v2.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2025 Abbott. All Rights Reserved.

MAT-2001111 v8.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0